Kinnos Raises $6 Million Investment Round, Led by Prolog Ventures, to Advance the Standard of Infection Prevention with Disinfection You Can See
Kinnos, an infection prevention company transforming patient safety and hospital efficiency, announces that it has closed a new $6 million investment round. Known for pioneering colorized disinfection, Kinnos will use the funding to accelerate its growth and new product development. Prolog Ventures, a venture capital firm that backs early-stage, high-growth health and wellness companies, invested $4.3 million to lead the round, which also included Allston Venture Fund, Partnership Fund for New York City, Golden Seeds, MEDA Angels, and several notable individual investors from the worlds of healthcare and business.
“We are thrilled to be partnering with both institutional investors and industry veterans to build Kinnos into the global standard of effective infection prevention,” said Jason Kang, co-founder and CEO of Kinnos. “As long as infectious diseases continue to threaten our health and safety, Kinnos will be at the forefront of innovating solutions that protect patients, health workers, and friends and family from infections.”